Xeris Pharmaceuticals | XERS - Ação





Ação Alterar Data
Celltrion KRW 122.94B 2.59T 2025-12
Cspc Pharmaceutical CNY 2.87B 259.23M 2025-06
Divis Laboratories Ltd INR 32.36B 910M 2025-03
Eli Lilly USD 14.53B 785M 2026-03
Kangmei Pharma CNY 2.38B 73.9M 2026-03
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Medical Developments International AUD 9.45M 679K 2025-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Organigram Holdings CAD 132.71M 8.76M 2025-12
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Pharma Mar EUR 53.12M 2.48M 2026-03
Qiagen NV USD 301.89M 11.66M 2025-12
Sartorius EUR 827.1M 34.9M 2026-03
Sino Biopharmaceutical CNY 1.84B 156.17M 2024-06
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
Tilray USD 282.79M 11.9M 2025-06
Zealand Pharma A/S 10.7M 9.9M 2024-12
Zz Pientze Pharmaceu CNY 6.28B 553.86M 2026-03